AIM ImmunoTech Inc (AIM)
0.19
0.00 (0.00%)
USD |
NYAM |
Dec 20, 16:00
0.195
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Profit Margin (Quarterly): -10.57K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 18.02% |
| Electromed Inc | 10.05% |
| Xtant Medical Holdings Inc | -17.98% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -256.3% |
| Return on Assets | -129.0% |
| Return on Invested Capital | -219.1% |
| Gross Profit Margin (Quarterly) | 77.14% |
| Operating Margin (Quarterly) | -12.83K% |
| Return on Net Operating Assets | -696.3% |